Adverse Drug Reactions With Fatal Outcome
1 other identifier
observational
1,135
0 countries
N/A
Brief Summary
The purpose of this study is to determine the incidence of drug-related deaths in a university hospital during the year 2015
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2016
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 13, 2016
CompletedFirst Posted
Study publicly available on registry
July 20, 2016
CompletedJuly 20, 2016
July 1, 2016
4 months
July 13, 2016
July 15, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of drug-related deaths of all hospital admissions
during the year 2015
Secondary Outcomes (10)
Number of drug-related deaths with the suspected drug started the previous week
during the year 2015
Number of drug-related deaths with drug interactions between suspected drugs
during the year 2015
Number of preventable drug-related deaths assessed by Schumock criteria
during the year 2015
Number of drug-related deaths with polypharmacy
during the year 2015
Number of drug-related deaths with autopsy
during the year 2015
- +5 more secondary outcomes
Study Arms (2)
Drug-related deaths
fatal adverse drug reactions
non drug-related deaths
deaths for other causes different as drugs
Interventions
Eligibility Criteria
All inpatients dead in the Germans Trias i Pujol University Hospital during the year 2015. Patients with a death diagnosis in a predefined list of medical conditions, potentially caused by drugs, were the selected cases for further review.
You may qualify if:
- inpatients deaths and drug-related deaths.
You may not qualify if:
- death patients in the emergency room, patients with a death diagnosis not available, and dead patients due to other causes non-drug related.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eva Montané, PhD
Department of Clinical Pharmacology. Hospital Universitari Germans Trias i Pujol. Badalona, Barcelona, Spain
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Pharmacologist
Study Record Dates
First Submitted
July 13, 2016
First Posted
July 20, 2016
Study Start
February 1, 2016
Primary Completion
June 1, 2016
Study Completion
July 1, 2016
Last Updated
July 20, 2016
Record last verified: 2016-07
Data Sharing
- IPD Sharing
- Will not share